CERENEX Trademark

Trademark Overview

On Wednesday, March 11, 1992, a trademark application was filed for CERENEX with the United States Patent and Trademark Office. The USPTO has given the CERENEX trademark a serial number of 74254364. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Sunday, March 17, 2002. This trademark is owned by Glaxo, Inc.. The CERENEX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances used for the treatment and/or alleviation of central nervous system disorders including headache, migraine and anti-emetic preparations

General Information

Serial Number74254364
Word MarkCERENEX
Filing DateWednesday, March 11, 1992
Status710 - CANCELLED - SECTION 8
Status DateSunday, March 17, 2002
Registration Number1882771
Registration DateTuesday, March 7, 1995
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 2, 1993

Trademark Statements

Goods and Servicespharmaceutical preparations and substances used for the treatment and/or alleviation of central nervous system disorders including headache, migraine and anti-emetic preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSunday, March 17, 2002
Primary Code005
First Use Anywhere DateWednesday, March 17, 1993
First Use In Commerce DateWednesday, March 17, 1993

Trademark Owner History

Party NameGlaxo, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
Party NameGlaxo, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
Party NameGlaxo, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Trademark Events

Event DateEvent Description
Tuesday, May 19, 2009REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, May 6, 2009PAPER RECEIVED
Wednesday, October 1, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 1, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 24, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 24, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 24, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 27, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 20, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, March 17, 2002CANCELLED SEC. 8 (6-YR)
Tuesday, March 7, 1995REGISTERED-PRINCIPAL REGISTER
Monday, October 31, 1994ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 3, 1994CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 23, 1994FINAL REFUSAL MAILED
Monday, July 11, 1994CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 1994NON-FINAL ACTION MAILED
Saturday, April 30, 1994STATEMENT OF USE PROCESSING COMPLETE
Monday, March 28, 1994USE AMENDMENT FILED
Saturday, April 30, 1994EXTENSION 1 GRANTED
Monday, March 28, 1994EXTENSION 1 FILED
Tuesday, November 16, 1993NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 2, 1993PUBLISHED FOR OPPOSITION
Monday, January 4, 1993NOTICE OF PUBLICATION
Tuesday, November 10, 1992APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 5, 1992EXAMINER'S AMENDMENT MAILED
Wednesday, June 3, 1992NON-FINAL ACTION MAILED
Thursday, May 14, 1992ASSIGNED TO EXAMINER
Thursday, May 14, 1992ASSIGNED TO EXAMINER

Related Keywords

cerenex preparations including disorders headache anti emetic system migraine nervous used